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Abstract
The healing of long bone fractures in dogs is an unsure and lengthy
process if the bones cannot be anatomically reconstructed or if the physical
status of the patient is less than ideal. If not assisted, the most likely result
is a non-union. A non-union is when the fracture site heals without bone
formation. The resulting fibrous tissue forms a pseudo j oint which moves
when subjected to muscle forces, causing considerable pain in the patient.
Long bone fractures are usually corrected through the use of internal or
external fixation devices. These devices lengthen healing time and usually
require a surgical procedure to implant or fix them in place.

Delayed

healing can also lead to muscle atrophy, j oint stiffness, and even refracture
of the bone.
The purpose of this project is to examine the effect of the addition of
canine growth hormone on the healing of long bone fractures in dogs.
Growth hormone has effects on cartilage and bone and has been proved to
enhance fracture healing in laboratory rodents. There are also reports of its
use in the treatment of delayed union fractures in geriatric humans.
This experiment will investigate the effects of recombinant growth
hormone administered via a subcutaneous implant on bone healing in a non
rigid fracture healing model. Non-rigid refers to the fact that during the
healing process, the ends of the fractured bones will not be fixed or splinted
in any way. Mature dogs, which have a low growth hormone concentration
and production compared to immature dogs, will be used. The degree of
healing will be assessed radiographically, photodensitometrically, and
scintigraphically. Force plate gait analysis will be used to determine the
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functional use of the affected limb. Finally, biomechanical tests in three
point bending will evaluate the mechanical strength of the bone healing by
determining the stiffness and ultimate strength of the healed bone in relation
to that of the intact radius.
This study will provide important information about the quality and
time of bone healing in dogs treated with exogenous growth hormone.
Although this study will concentrate only on bone healing in dogs, valuable
comparative data will be obtained.

Future studies may be able to

extrapolate this and other data to the study of human fracture healing.

Motive and History

Serious fractures of the long bones are common in dogs.

Due to

small bone fragment size or missing fragments, such fractures can not
always be reduced or stabilized through the use of fixation devices.
Secondary bone healing, or healing through the formation of a bony callus
around the fracture site, occurs when there is a ga1J wider than 1 mm
between fracture ends, or when the fracture site is non-rigid. Missing bone
fragments can cause extraordinarily large forces to be placed on fixation
devices. These forces coupled with the delayed healing time can cause
premature failure of the device and can lead to refracture of the bone.
The effects of the growth hormone somatotropin (ST) on cells of
bone and cartilage have been investigated both in the body and in a
laboratory environment. ST stimulates bone growth along the axis of the
bone by stimulating the local production of insulin-like growth factor I,
which is one of the key factors in bone repair. Most of the early studies
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have focused on using rats with human or bovine growth hormone. Despite
the fact that these studies used a wide range of dose levels, length of
treatment, and source, nearly all of them showed a stimulatory effect on
bone healing in patients subj ected to growth hormone.
To date no complete studies have focused on the influence of canine
growth hormone on the radiographic, scintigraphic, functional, and
biomechanical aspects of the healing of long bone fractures in dogs. A
radial ostectomy, or the removal of a piece of the front limb bone known as
the radius, will allow the evaluation of fracture healing in a non-rigid model
while mini zing patient discomfort. The discomfort of the patient will be
minimized by leaving the ulna, next to the radius, intact and allowing the
weight of the animal to be shared by the intact bone.
Radiographic changes are one of the most widely used indicators
used to assess fracture healing. Radiographic analysis is done by injecting a
harmless radioactive isotope into the animal at the fracture site.

This

isotope is taken up by the tissue surrounding the site and when examined
through a device which allows the viewing of the isotope, a picture of the
healing site can be generated. Photodensitometry provides a more accurate
estimate of bone mineral content by comparing the absorbance of light
through a point on the radiograph to the absorbance through a standard
medium.
Nuclear scintigraphy is a good indicator of the level of bone cell and
vascular activity.

Technetium 99 is a commonly used radionucleide

because its uptake correlates well with active bone metabolism as well as
capillary budding. During fracture healing, capillaries bud into the fracture
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site and provide extra nutrients to the osteoblastic, or bone producing, cells.
Growth hormone has a positive effect on capillary budding. The use of
growth hormone may increase the amount of budding taking place in the
fracture and increase the level of bone production, hence speeding the
healing process.
Weightbearing by the injured limb can provide effective information
about the functional use of the fracture during healing. Force plate gait
analysis provides information regarding the vertical, horizontal, breaking,
and propulsive forces placed on the injured limb. Because one of the goals
of this study is to decrease the healing time and return the patient to full use
of the fractured limb as soon as possible, this information is vital to the
assessment of the quality of the bone healing. If the growth hormone has a
positive effect on the healing time, the dogs treated with it should place
more weight on the injured limb sooner than the untreated dogs.
Biomechanical testing will provide data regarding the actual strength
and stiffness of the bone after fracture healing. A load vs. diaplacement
curve is generated when the bones are tested in three point bending as
shown in figures 1 and 2.

Force

2

3

1
figure 1: Example of three point bending
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Point of ultimate strength
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fracture

Load (lb)

Displacement (in)
figure 2: Sample load vs. displacement curve

To account for physical variations among the dogs, the biomechanical
information from the fractured radius will be compared to the data for the
intact radius for each dog.

Materials and Methods
Eight healthy, mature, female beagle dogs weighing between 20 and
25 lb were allocated into two groups of four. The dogs then underwent a
radial ostectomy of a random radius. A 3 mm section of the radius was
removed from one radius of each dog.

One group of dogs received

somatotropin growth hormone via a subcutaneous implant during healing
while the other control group received a saline placebo.

The implants

release 4 mg of somatotropin per day for 42 days. These implants were a
gift from the Monsanto Company (Dr. Frances Buonomo). The dogs were
kept at a relatively constant weight level throughout the study. They were
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allowed unrestrained movement during healing to promote the non-rigid
fracture model.

Radiographic Evaluation

Dogs were sedated with acepromazine (.05 mg/lb) and butorphanol
(.1 mg/lb). Radiographs from the lateral and front views were taken prior to
surgery, immediately following surgery, and at 2, 4, 6, and 8 weeks during
the course of the project. A standard aluminum stepwedge was placed on
the

radiograph

to

provide

radiographic

density

controls

for

photodensitometric scanning.
Fracture healing was assessed blindly by a board certified veterinary
radiologist (Dr. Greg Daniel).

Healing was assessed by examining the

callus formation, cellular reaction, and gap distance between bone ends.
Photo densitometric measurements were taken to determine the bone
density.

Nuclear Scintigraphy

While the dogs are sedated for the radiographic tests, nuclear scans of
the fractured radius were made.

These scans were also performed prior to

surgery as well as 2, 4, 6, and 8 weeks during the course of the study.
Scans were run by administering 20 me of 99Technitium methylene
diphosphonate by intravenous injection. Two hours following injection, a
large field gamma camera was used to produce images of the healing bone.
Each picture was assessed by Dr. Greg Daniel to evaluate isotope
accumulation at the fracture site in relation to the normal adjacent bone.
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Uptake of the iosotope in the fractured limb was compared to that of the
intact limb.

Force Plate Gait Analysis
An AMTI Model OR6-6 force plate was used to obtain information

on the functional use of the injured limb. Tests were run prior to surgery
and at 2, 4, 6, and 8 weeks after surgery. The dogs were were trotted across
the plate at velocities from 2.1 to 2.4 m/s for three trials for each dog.
Through this test, the peak vertical force, breaking force, and propulsive
forces were measured.

Biomechanical Testing
At the end of the eight week testing period, the dogs were euthanized
and both the intact and fractured radii from each dog were surgically
removed. The bones were then radiographed and then subjected to three
point bending tests performed on an Instron testing machine. A downward
deflection was applied at 2 mm/min until failure of the specimen was
achieved. A load vs. displacement curve was generated for each tested
bone. From these curves, the stiffness (elastic modulus), ultimate strength,
and area under the curve were evaluated for the intact and fractured radii.
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Results
Radiographic results:
Radiographs of the dogs treated with somatotropin showed increased
fracture healing. There was a great deal of callus formation and nearly
reached union at the end of the 8 week period. Untreated dogs had little
callus formation and slow fracture healing. The bones were progressing to
non-union. Charts 1-3 show the total length, thickness and amount of callus
measured for the treated vs. untreated dogs.
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chart 3: Total bone callus measured
The total length, thickness, and amount of the callus was nearly 3 times
greater in the dogs receiving somatotropin than in the control dogs.
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Nuclear Scintigraphic Results
All dogs showed increased 99 Tc absroption at the fracture sites. Some
remodeling was noticed in the ulnas due to the increased force placed on
them during weight bearing.

The somatotropin treated dogs showed a

single active region at the fracture site while the untreated dogs maintained
2 separate regions.
Through ostectomy analysis, the bone and muscle density ratios for
the dogs were calculated.

The bone ratio of the humerus was 30% greater

at 2 weeks in the treated dogs. This increase persisted throughout the study.
The muscle count density ratio was the same for 4 weeks, but by 6 and 8
weeks, the ratios were 90% and 60% greater in treated dogs, respectively.
Charts 4 and 5 show these results graphically.

Chart 6 shows the

comparisons of the bone area, mineral content, and bone mineral densities
for the control and treated dogs.
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chart 6: Bone comarisons at fracture site

The area, bone mineral content, and bone mineral density of the healing
fracture site were 2.5, 5, and 2 times greater, respectively, in dogs treated
with somatotropin than in untreated dogs.
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Biomechanical Results
The three point bending tests yielded the ultimate strength and
stiffness of the intact and fractured radii. The fractured radii of dogs treated
with somatotropin were 3 times stronger than fractured radii of untreated
dogs (chart 7). The somatotropin did not have an effect on the unfractured
contralateral radii (chart 8). Fractured radii of dogs treated with
somatotropin were 5-6 times stiffer than fractured radii of untreated dogs
(chart 9). Once again, the somatotropin did not have an effect on the
unfractured contralateral radii (chart 10).
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Conclusion
The addition of somatotropin has a profound positive effect on the
healing of fractures in dogs. The radiographs all showed increased bone
callus and bone density in the treated dogs vs. the untreated dogs. The
fracture site showed a unified active site under scintigraphic analysis for the
treated dogs. This means that the fracture was progressing to a bony union.
The untreated dogs maintained two distinct active sites at the point of
fracture, meaning that the bone was progressing to a nonunion.
The ultimate test of fracture healing is the strength of the bone under
load bearing.

Strength and stiffness of bone can be related to the total

volume of bone, the bone mineral content present, and the density of the
bone. In all of the treated dogs, the ultimate strength was about 3 larger and
the stiffness was 5 to 6 times larger than those of the untreaded dogs.

Future Studies
Future studies should be run to provide other necessary information
about the use of somatotropin for fracture healing. Valuable informantion
should include finding an optimal dose level and method of administration
of the hormone. Physiological repercussions such as systemic short term
and long term effects may be studied as well. Other fracture models besides
non-rigid should be examined.

Finally, clinical studies should also be

pursued.
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